- 06.10.2011, 07:04:33
- /
- OTE0001
Investigational Oral Multiple Sclerosis Therapy Teriflunomide (Aubagio?(*)) Significantly Reduced Relapse Rate, Disability Progression and Disease Activity
OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | PRN
